Bayer Oncology at ASCO 2024. For the last three years, Bayer has been implementing a new strategy for its oncology development, a strategy that led to multiple approvals, as well as a number of ...
Bayer is entering a defining period, with critical legal decisions and a strategic management overhaul in the United States set to chart its course for the comi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results